US Court of Appeals Affirms Decision Finding Seroquel XR Formulation Patent Valid and Infringed

Friday, 15 February 2013 AstraZeneca today announced that, on 14 February 2013, the United States Court of Appeals for the Federal Circuit summarily upheld a lower court ruling that had found the formulation patent protecting SEROQUEL XR (quetiapine...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news